Absence of PSA Flare With Apalutamide Administered 1 Hour in Advance With GnRH Agonists: Case Report

OBJECTIVE: To examine the effects of apalutamide on endocrine function and flare prevention in metastatic hormone-sensitive prostate cancer (mHSPC) patients administered GnRH agonists. METHODS: The first newly diagnosed mHSPC patient took apalutamide for 2 weeks followed by combination with GnRH ago...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Zhiquan, Liu, Zhenghao, Chen, Zhiyuan, Zeng, Xing, Wang, Zhihua, Yang, Chunguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193224/
https://www.ncbi.nlm.nih.gov/pubmed/35712513
http://dx.doi.org/10.3389/fonc.2022.878264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9193224/
https://www.ncbi.nlm.nih.gov/pubmed/35712513
http://dx.doi.org/10.3389/fonc.2022.878264

Ejemplares similares